home / stock / nevpf / nevpf short
Short Information | Neurovive Pharm Ab Ord (OTCMKTS:NEVPF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 11,426 |
Total Actual Volume | 31,551 |
Short Trends | |
---|---|
Cover Days | 4 |
Short Days | 16 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 571 |
Average Short Percentage | 81.04% |
Is there a NEVPF Short Squeeze or Breakout about to happen?
See the NEVPF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
11-30-2021 | $0.075 | $0.075 | $0.075 | $0.075 | 1,100 | 1,100 | 100% |
11-26-2021 | $0.08 | $0.08 | $0.08 | $0.08 | 6,000 | 1,000 | 16.67% |
11-24-2021 | $0.075 | $0.075 | $0.075 | $0.075 | 600 | 600 | 100% |
11-22-2021 | $0.065 | $0.065 | $0.065 | $0.065 | 2,000 | 2,000 | 100% |
11-19-2021 | $0.075 | $0.075 | $0.075 | $0.075 | 200 | 200 | 100% |
11-18-2021 | $0.075 | $0.075 | $0.075 | $0.075 | 110 | 110 | 100% |
11-17-2021 | $0.08 | $0.07 | $0.08 | $0.07 | 5,130 | 130 | 2.53% |
11-16-2021 | $0.07 | $0.07 | $0.07 | $0.07 | 125 | 125 | 100% |
11-15-2021 | $0.08 | $0.08 | $0.08 | $0.08 | 100 | 100 | 100% |
11-11-2021 | $0.065 | $0.065 | $0.065 | $0.065 | 5,110 | 110 | 2.15% |
11-10-2021 | $0.07 | $0.07 | $0.07 | $0.07 | 100 | 100 | 100% |
11-08-2021 | $0.09 | $0.09 | $0.09 | $0.09 | 101 | 101 | 100% |
11-05-2021 | $0.07 | $0.07 | $0.07 | $0.07 | 5,125 | 5,000 | 97.56% |
10-29-2021 | $0.07 | $0.07 | $0.07 | $0.07 | 133 | 133 | 100% |
10-25-2021 | $0.065 | $0.065 | $0.065 | $0.065 | 5,100 | 100 | 1.96% |
10-14-2021 | $0.07 | $0.07 | $0.07 | $0.07 | 105 | 105 | 100% |
10-08-2021 | $0.07 | $0.07 | $0.07 | $0.07 | 100 | 100 | 100% |
10-07-2021 | $0.075 | $0.075 | $0.075 | $0.075 | 101 | 101 | 100% |
10-06-2021 | $0.07 | $0.07 | $0.07 | $0.07 | 111 | 111 | 100% |
09-29-2021 | $0.08 | $0.08 | $0.08 | $0.08 | 100 | 100 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Neurovive Pharm Ab Ord Company Name:
NEVPF Stock Symbol:
OTCMKTS Market:
STOCKHOLM , Feb. 19, 2020 /PRNewswire/ -- Important events in 2019 KL1333 NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study &...
LUND, Sweden , Dec. 16, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) announced today that it has fully and finally settled the dispute with CicloMulsion AG regarding certain pharmaceutical technology. In 2004, NeuroVive entered into a License A...
- Continued Progress in KL1333 STOCKHOLM , Nov. 20, 2019 /PRNewswire/ -- Important events July - September NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study NeuroSTAT receives Fast Track designation from the US Food and Drug Administration. ...